Breast-ovarian Cancer, Familial, Susceptibility To, 3; Brovca3
Genes related to Breast-ovarian Cancer, Familial, Susceptibility To, 3; Brovca3
- RAD51C
Clinical Features
Phenotypes and symptoms related to Breast-ovarian Cancer, Familial, Susceptibility To, 3; Brovca3
- Neoplasm
- Breast carcinoma
- Ovarian neoplasm
- Ovarian carcinoma
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— The onset for some of the known clinical features related to this disease may vary, including middle age onset, and middle age onset .
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Breast-ovarian Cancer, Familial, Susceptibility To, 3; Brovca3 Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
Comprehensive Hereditary Cancer Panel.
By Baylor Miraca Genetics Laboratories (United States).
RUNX1, SDHA, SDHB, SDHC, SDHD, BMPR1A, BRCA1, BRCA2, STK11, EPCAM, TP53, VHL, WT1, CBL, SUFU, CDC73, CDH1, CDK4, CDKN1C, CDKN2A , (...)
View the complete list with 39 more genes
Specificity
2 %
Genes
100 % |
Comprehensive breast and ovarian cancer panel testing (18 genes).
By Molecular Genetics Laboratory Centro de Investigaciones Endocrinologicas "Dr. Cesar Bergada" (Argentina).
BRCA1, BRCA2, STK11, EPCAM, TP53, CDH1, BRIP1, PALB2, MLH1, MSH2, MSH6, MUTYH, ATM, PMS2, PTEN, RAD51C, RAD51D
Specificity
6 %
Genes
100 % |
Fanconi Anemia Panel.
By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States).
BRCA2, BRIP1, FANCL, FANCM, SLX4, FANCI, PALB2, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, RAD51C
Specificity
7 %
Genes
100 % |
Inherited Cancer Panel.
By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States).
BLM, SDHB, BMPR1A, BRCA1, BRCA2, STK11, EPCAM, TP53, TSC1, TSC2, VHL, XRCC2, CDC73, CDH1, CDK4, CDKN1B, CDKN2A, BRIP1, SDHAF2, TMEM127 , (...)
View the complete list with 28 more genes
Specificity
3 %
Genes
100 % |
Bone Marrow Failure.
By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States).
RPL11, RPL35A, RPL5, RPS10, RPS15, RPS19, RPS24, RPS26, RPS27A, RPS7, BRCA2, SRP72, TERT, THPO, TINF2, XRCC2, RPL36, NHP2, NOP10, SBDS , (...)
View the complete list with 23 more genes
Specificity
3 %
Genes
100 % |
VistaSeq Hereditary Cancer Panel.
By Molecular Diagnostic Laboratory University of Alberta (Canada).
BMPR1A, BRCA1, BRCA2, STK11, EPCAM, TP53, CDH1, CDK4, CDKN2A, BRIP1, ABRAXAS1, PALB2, APC, SMAD4, MLH1, MSH2, MSH6, MUTYH, NBN, ATM , (...)
View the complete list with 6 more genes
Specificity
4 %
Genes
100 % |
Vistaseq Hereditary Cancer Panel Without BRCA.
By Molecular Diagnostic Laboratory University of Alberta (Canada).
BMPR1A, STK11, EPCAM, TP53, CDH1, CDK4, CDKN2A, BRIP1, ABRAXAS1, PALB2, APC, SMAD4, MLH1, MSH2, MSH6, MUTYH, NBN, ATM, PMS2, PRKAR1A , (...)
View the complete list with 4 more genes
Specificity
5 %
Genes
100 % |
VisaSeq Breast and GYN Cancer Panel.
By Molecular Diagnostic Laboratory University of Alberta (Canada).
BRCA1, BRCA2, STK11, EPCAM, TP53, CDH1, BRIP1, ABRAXAS1, PALB2, FANCC, MLH1, MRE11, MSH2, MSH6, MUTYH, NBN, NF1, ATM, PMS2, BARD1 , (...)
View the complete list with 4 more genes
Specificity
5 %
Genes
100 % |
You can get up to 145 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM Genetic Syndrome FinderIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2 XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4 ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 4; EKVP4 EMANUEL SYNDROME CUTANEOUS TELANGIECTASIA AND CANCER SYNDROME, FAMILIAL; FCTCS CANDIDIASIS, FAMILIAL, 2; CANDF2